NCT01844648View on ClinicalTrials.gov

Study of the Safety and Efficacy of Tropicamide Thin Films to Reduce Hypersalivation in Parkinson's Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

October 31, 2015

Study Completion Date

December 31, 2015

Conditions
Sialorrhea (Excessive Drooling)
Interventions
DRUG

NH004 tropicamide

Intra-oral slow dissolving muco-adhesive thin film containing 1 mg tropicamide

DRUG

NH004 Placebo

Intra-oral slow dissolving muco-adhesive thin film

Trial Locations (3)

31059

Hôpital Paul de Viguier, Toulouse

33604

Hôpital Haut Lévêque, Bordeaux

75651

Hôpital de la Salpêtrière, Paris

Sponsors
All Listed Sponsors
collaborator

Michael J. Fox Foundation for Parkinson's Research

OTHER

lead

NeuroHealing Pharmaceuticals Inc.

INDUSTRY

NCT01844648 - Study of the Safety and Efficacy of Tropicamide Thin Films to Reduce Hypersalivation in Parkinson's Patients | Biotech Hunter | Biotech Hunter